Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice.
Recent evidence indicates that toll-like receptor (TLR) 2 and 4 are involved in the pathogenesis of dilated cardiomyopathy (DCM), but the exact mechanisms of their actions have not been elucidated. We explored the therapeutic potential of blocking TLRs in mice with established cardiomyopathy. Cardio...
Guardado en:
Autores principales: | Yonggang Ma, Xiaowei Zhang, Huayan Bao, Su Mi, Wenfeng Cai, Huimin Yan, Qingqing Wang, Ziyan Wang, Jun Yan, Guo-Chang Fan, Merry L Lindsey, Zhuowei Hu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57bd32d6ad9c48acab6e47ee9176c79a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease.
por: Simona E Budulac, et al.
Publicado: (2012) -
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
por: Amani E. Khalifa, PhD, et al.
Publicado: (2021) -
The heterogeneous allelic repertoire of human toll-like receptor (TLR) genes.
por: Philippe Georgel, et al.
Publicado: (2009) -
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
por: Katja Derkow, et al.
Publicado: (2013) -
TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
por: Anastazja M. Gorecki, et al.
Publicado: (2021)